ZyVersa Therapeutics Inc (NASDAQ:ZVSA) has a beta value of 0.78 and has seen 11.92 million shares traded in the recent trading session. The company, currently valued at $3.35M, closed the recent trade at $0.7 per share which meant it gained $0.04 on the day or 6.38% during that session. The ZVSA stock price is -800.0% off its 52-week high price of $6.30 and 32.86% above the 52-week low of $0.47. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.63 million shares traded. The 3-month trading volume is 3.72 million shares.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Sporting 6.38% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ZVSA stock price touched $0.7 or saw a rise of 4.1%. Year-to-date, ZyVersa Therapeutics Inc shares have moved -82.53%, while the 5-day performance has seen it change 9.70%. Over the past 30 days, the shares of ZyVersa Therapeutics Inc (NASDAQ:ZVSA) have changed 30.02%. Short interest in the company has seen 0.3 million shares shorted with days to cover at 0.08.
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
The company’s shares have lost -43.38% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 58.00% over the past 5 years.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next earnings report on 2024-Nov-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Insiders own 0.13% of the company shares, while shares held by institutions stand at 7.43% with a share float percentage of 7.45%. Investors are also buoyed by the number of investors in a company, with ZyVersa Therapeutics Inc having a total of 8.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Apr 30, 2025 , the former fund manager holds about 0.38% shares in the company for having 18.08 shares of worth $12981.0 while later fund manager owns 3.63 shares of worth $2603.0 as of Apr 30, 2025 , which makes it owner of about 0.08% of company’s outstanding stock.
